Relapsing Kaposi's varicelliform eruption and herpes simplex following facial tacrolimus treatment for atopic dermatitis

被引:18
作者
Ambo, M [1 ]
机构
[1] Bibai Rosai Hosp, Labor Welf Corp, Dept Dermatol, Bibai 0720015, Japan
关键词
D O I
10.1080/00015550260132622
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
引用
收藏
页码:224 / 225
页数:2
相关论文
共 8 条
[1]  
BRAUNFALCO O, 1991, DERMATOLOGY, P26
[2]  
Frankel S J, 2001, Skin Therapy Lett, V6, P1
[3]  
FRANKEL SJ, 2001, SKIN THERAPY LETT, V6, P5
[4]   Safe and effective treatment of refractory facial lesions in atopic dermatitis using topical tacrolimus following corticosteroid discontinuation [J].
Kawakami, T ;
Soma, Y ;
Morita, E ;
Koro, O ;
Yamamoto, S ;
Nakamura, K ;
Tamaki, K ;
Yajima, K ;
Imaizumi, A ;
Matsunaga, R ;
Murakami, N ;
Kashima, M ;
Mizoguchi, M .
DERMATOLOGY, 2001, 203 (01) :32-37
[5]   Eczema herpeticum during treatment of atopic dermatitis with 0.1% tacrolimus ointment [J].
Lübbe, J ;
Pournaras, CC ;
Saurat, JH .
DERMATOLOGY, 2000, 201 (03) :249-251
[6]  
NAGINGTON J, 1986, TXB DERMATOLOGY, P691
[7]   Safety and efficacy of 1 year of tacrolimus ointment monotherapy in adults with atopic dermatitis [J].
Reitamo, S ;
Wollenberg, A ;
Schöpf, E ;
Perrot, JL ;
Marks, R ;
Ruzicka, T ;
Christophers, E ;
Kapp, A ;
Lahfa, M ;
Rubins, A ;
Jablonska, S ;
Rustin, M .
ARCHIVES OF DERMATOLOGY, 2000, 136 (08) :999-1006
[8]   Tacrolimus suppressed the production of cytokines involved in atopic dermatitis by direct stimulation of human PBMC system. (Comparison with steroids) [J].
Sakuma, S ;
Higashi, Y ;
Sato, N ;
Sasakawa, T ;
Sengoku, T ;
Ohkubo, Y ;
Amaya, T ;
Goto, T .
INTERNATIONAL IMMUNOPHARMACOLOGY, 2001, 1 (06) :1219-1226